3006.30.10.00/Rabies Vaccine for Human Use/Canada

Rabies Vaccine for Human Use from Canada

This diagnostic reagent contains inactivated rabies virus antigens used for pre-exposure prophylaxis and post-exposure treatment in humans. It falls under HTS 3006.30.10.00 as it is a preparation containing antigens designed to be administered to the patient for immunological testing or vaccination. The product is put up in measured doses for direct injection.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Obtain FDA approval and biologics license; provide lot release certificates from manufacturer

• Maintain strict cold chain documentation (2-8°C) to avoid spoilage claims at customs

• Declare exact antigen content; mislabeling can lead to reclassification or penalties